Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B

Table 3 Correlation between cholesterol to high-density lipoprotein cholesterol and nonalcoholic fatty liver disease in different models

Variable	Model 1			Model 2			Model 3
	OR	95%CI	P value	OR	95%CI	P value	OR	95%CI	P value
TC/HDL-C	0.94	1.55-4.19)	< 0.01	0.96	(1.52-4.51)	< 0.01	-2.27	(0.01-79.91)	0.5
TC/HDL-C
≤ 3.5	Reference			Reference			Reference
3.5-5	-2.53	(0.01-0.48)	0.01	1.59	(1.10-21.94)	0.04	-0.64	(0.04-6.77)	0.63
> 5	-0.77	(0.14-1.50)	0.2	2.29	(1.60-61.40)	0.01	-1.74	(0.01-14.45)	0.44
P for trend	0.02			0.05			0.73

Model 1 was not adjusted for other pertinent clinical variables.

Model 2 was adjusted according to gender and age.

Model 3 was adjusted according to gender, age, body mass index, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transpeptidase, platelets, Hepatitis B virus surface antigen, creatinine, uric acid, triglyceride, total cholesterol, High-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, Apolipoprotein A1, Apolipoprotein B, Hepatitis B virus DNA > 100 IU/mL, Hepatitis B e antigen positive, nucleoside analogues. CI: Confidence interval; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol.